Tue, Sep 30, 2014, 12:10 PM EDT - U.S. Markets close in 3 hrs 50 mins

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • clemcaldwell clemcaldwell Sep 20, 2013 3:58 PM Flag

    Biomarker for lung cancer.

    Mayo Clinic researchers have shown that a specific pair of proteins in smokers have potential as a biomarker for lung cancer.
    "This is exciting because we've found what we believe to be a 'drugable target' here," Mayo molecular-medicine researcher and senior study author George Vasmatzis said. "It's a clear biomarker for aggressive adenocarcinomas. These are the fast-growing cancer cells found in smokers' lungs."
    The protein ASCL1 is associated with expression of a cancer-causing gene called RET. ASCL1 is already known to affect thyroid and small-cell lung cancer development. But the link to lung cancer wasn't previously known.

 
EXEL
1.549-0.041(-2.58%)12:10 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.